FLT3-ITDs Introduce a Myeloid Differentiation and Transformation Bias to Multipotent Lympho-Myeloid Progenitors
Mead AJ. et al, (2011), BLOOD, 118, 604 - 604
Germline Activating JAK2 V617I Mutation, in a Family with Hereditary Thrombocytosis
Mead AJ. et al, (2011), BLOOD, 118, 758 - 759
The Effect of Eltrombopag on Platelet Resistance to Apoptosis: The Role of the Bcl-Xl Pathway
Mitchell WB. et al, (2011), BLOOD, 118, 524 - 524
Differences in platelet function in patients with acute myeloid leukemia and myelodysplasia compared to equally thrombocytopenic patients with immune thrombocytopenia.
Psaila B. et al, (2011), J Thromb Haemost, 9, 2302 - 2310
Periampullary Cancer ESPAC-3(v2) trial: a Randomised Controlled Phase III Trial of Adjuvant Chemotherapy Versus Observation in Patients With Periampullary Adenocarcinomas of the Head of the Pancreas
Neoptolemos J. et al, (2011), PANCREAS, 40, 1343 - 1343
Continuous low-dose cyclophosphamide and methotrexate combined with celecoxib for patients with advanced cancer (vol 104, pg 1822, 2011)
Khan OA. et al, (2011), BRITISH JOURNAL OF CANCER, 105, 1252 - 1252
Erratum: Continuous low-dose cyclophosphamide and methotrexate combined with celecoxib for patients with advanced cancer (British Journal of Cancer (2011) 104 (1822-1827) DOI:10.1038/bjc.2011.154)
Khan OA. et al, (2011), British Journal of Cancer, 105
Sentinel lymph node biopsy in melanoma: The Oxford ten year clinical experience
Rughani MG. et al, (2011), Journal of Plastic, Reconstructive and Aesthetic Surgery, 64, 1284 - 1290
Sentinel lymph node biopsy in melanoma: The Oxford ten year clinical experience.
Rughani MG. et al, (2011), J Plast Reconstr Aesthet Surg, 64, 1284 - 1290
Impact of gene dosage, loss of wild-type allele, and FLT3 ligand on Flt3-ITD-induced myeloproliferation.
Kharazi S. et al, (2011), Blood, 118, 3613 - 3621
A two-part phase II study of cediranib in patients with advanced solid tumours: the effect of food on single-dose pharmacokinetics and an evaluation of safety, efficacy and imaging pharmacodynamics.
Mitchell CL. et al, (2011), Cancer Chemother Pharmacol, 68, 631 - 641
Efficacy of Veliparib (ABT-888) Plus Temozolomide Versus Temozolomide Alone: a Randomized, Double-blind, Placebo-controlled Trial in Patients with Metastatic Melanoma
Middleton M. et al, (2011), EUROPEAN JOURNAL OF CANCER, 47, 8 - 8
Richter's syndrome of the brain and the spinal cord.
Graves TD. et al, (2011), J Neurol Neurosurg Psychiatry, 82, 943 - 944
A novel scoring system combining expression of CD23, CD20, and CD38 with platelet count predicts for the presence of the t(11;14) translocation of mantle cell lymphoma.
Medd PG. et al, (2011), Cytometry B Clin Cytom, 80, 230 - 237
A novel scoring system combining expression of CD23, CD20, and CD38 with platelet count predicts for the presence of the t(11;14) translocation of mantle cell lymphoma
Medd PG. et al, (2011), Cytometry Part B - Clinical Cytometry, 80 B, 230 - 237
Ampullary cancer ESPAC-3 (v2) trial: A multicenter, international, open-label, randomized controlled phase III trial of adjuvant chemotherapy versus observation in patients with adenocarcinoma of the ampulla of vater
Neoptolemos JP. et al, (2011), JOURNAL OF CLINICAL ONCOLOGY, 29
Continuous low-dose cyclophosphamide and methotrexate combined with celecoxib for patients with advanced cancer.
Khan OA. et al, (2011), Br J Cancer, 104, 1822 - 1827
Adverse reactions to Patent Blue v dye used in sentinel lymph node biopsy for Melanoma
Rughani MG. et al, (2011), European Journal of Plastic Surgery, 34, 201 - 204